Dual inhibition of angiogenesis by Peucedanum praeruptorum Dunn root extract in ...
연구 요약
Dual inhibition of angiogenesis by Peucedanum praeruptorum Dunn root extract in endothelial and gefitinib-resistant lung cancer cells.
Fitoterapia 학술지에 발표된 이 연구는 Park HJ, Park SH 외 연구팀이 수행하였습니다.
이 연구는 'Dual inhibition of angiogenesis by Peucedanum praeruptorum Dunn root extract in endothelial and gefitinib-resistant lung cancer cells.'에 대한 과학적 분석을 제공합니다.
핵심 내용
Peucedanum praeruptorum Dunn (PP) root, traditionally used in Korea to alleviate respiratory symptoms, has been reported to exhibit anticancer effects. In this study, we investigated the effects of an ethanolic extract of PP root (EPP) on tumor angiogenesis. The anti-angiogenic activity of EPP was evaluated in both endothelial and cancer cells. Our results showed that EPP significantly inhibited the proliferation, migration, tube formation, and permeability of human umbilical vein endothelial cells (HUVECs), indicating that EPP suppresses the angiogenic capacity of HUVECs. EPP also reduced VEGFR2 phosphorylation and the activation of its downstream targets, AKT and ERK. Conditioned medium (CM) from gefitinib-resistant PC9 (PC9/GR) cells promoted HUVEC migration, tube formation, and angiogenic factor expression compared with CM from parental PC9 cells, demonstrating the strong pro-angiogenic properties of PC9/GR cells. Notably, CM from PC9/GR cells treated with EPP (EPP CM) markedly suppressed these pro-angiogenic effects. EPP selectively downregulated angiopoietin-1 (ANG-1) in PC9/GR cells, and supplementation with recombinant human ANG-1 to EPP CM restored HUVEC migration. Praeruptorin A (PA) and praeruptorin B (PB), constituents of EPP, exhibited comparable anti-angiogenic activities in both HUVECs and PC9/GR cells and were predicted to bind the VEGFR2 kinase domain. Taken together, these findings suggest that EPP inhibits angiogenesis through dual mechanisms: direct inactivation of VEGFR2 in endothelial cells and attenuation of the pro-angiogenic potential of PC9/GR cells via ANG-1 downregulation. This study highlights the therapeutic potential of EPP as a natural anti-angiogenic agent.
일반인을 위한 해석
구체적인 실천 사항은 담당 의사 또는 약사와 상담하시기 바랍니다.
실천 사항
- 현재 복용 중인 약물이나 영양제에 대해 궁금한 점이 있다면 담당 의사 또는 약사와 상담하시기 바랍니다
- 약물이나 영양제의 용법·용량을 임의로 변경하지 마세요
- 이상 반응이 나타나면 즉시 전문가에게 문의하세요
의사/약사의 전문적 판단을 대체하지 않습니다 (PMID: 41241238)
이 연구와 관련된 약물을 복용 중인가요?
상호작용 체크하러 가기이 정보는 의학 논문의 요약이며, 의사/약사의 전문적 판단을 대체하지 않습니다.